# Oxybutynin Chloride

NDC: 72888-032
Generic name: Oxybutynin Chloride
Labeler / Manufacturer: Advagen Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20201027

FDA application: ANDA214415

## Active ingredients

- OXYBUTYNIN CHLORIDE: 15 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72888-032"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72888-032
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7bd31561-4c76-4c6b-819b-492549886673